"CAIN457A3404-REALIAA non-interventional, prospective 12-months study to characterize the REAL-life effectiveness and treatment patterns of SecukInumab and current standard of care inpatient with chronic plaque psoriAsis eligible for systemic treatment in the Asia-Pacific and Middle East regions"
2020-07-04
عنوان الدراسة
"CAIN457A3404-REALIAA non-interventional, prospective 12-months study to characterize the REAL-life effectiveness and treatment patterns of SecukInumab and current standard of care inpatient with chronic plaque psoriAsis eligible for systemic treatment in the Asia-Pacific and Middle East regions"
داعم الدراسة
Novartis
دواء الدراسة
Cosyntex
رقم بروتوكول الدراسة
IN457A3404
حالة الدراسة
Ongoing
موقع الدراسة
King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)
مرحلة الدراسة
4
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.